Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

2.

Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.

Arnold JD, Dart BW, Barker DE, Maxwell RA, Burkholder HC, Mejia VA, Smith PW, Longley JM.

Am Surg. 2010 Jun;76(6):563-70.

PMID:
20583509
3.

Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.

Borkgren-Okonek MJ, Hart RW, Pantano JE, Rantis PC Jr, Guske PJ, Kane JM Jr, Gordon N, Sambol NC.

Surg Obes Relat Dis. 2008 Sep-Oct;4(5):625-31. doi: 10.1016/j.soard.2007.11.010. Epub 2008 Feb 8.

PMID:
18261965
4.

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.

Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW; THE-PRINCE Study Group.

Am Heart J. 2003 Apr;145(4):614-21.

PMID:
12679756
5.

Heparin thromboprophylaxis in gastric bypass surgery.

Shepherd MF, Rosborough TK, Schwartz ML.

Obes Surg. 2003 Apr;13(2):249-53.

PMID:
12740133
6.

Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury.

Hebbeler SL, Marciniak CM, Crandall S, Chen D, Nussbaum S, Mendelewski S.

J Spinal Cord Med. 2004;27(3):236-40.

PMID:
15478526
7.

Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.

Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group.

J Thromb Thrombolysis. 2005 Jun;19(3):173-81.

PMID:
16082604
8.

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

Ann Intern Med. 2004 Jun 1;140(11):867-73.

PMID:
15172900
9.

Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis.

Bushwitz J, LeClaire A, He J, Mozingo D.

J Burn Care Res. 2011 Nov-Dec;32(6):578-82. doi: 10.1097/BCR.0b013e31822dc3c7.

PMID:
21841495
10.

Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery.

F Shepherd M, Rosborough TK, Schwartz ML.

Obes Surg. 2004 May;14(5):601-5.

PMID:
15186625
11.

Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.

Slavik RS, Chan E, Gorman SK, de Lemos J, Chittock D, Simons RK, Wing PC, Ho SG.

J Trauma. 2007 May;62(5):1075-81; discussion 1081.

PMID:
17495705
12.

Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.

Hillbom M, Erilä T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M.

Acta Neurol Scand. 2002 Aug;106(2):84-92.

PMID:
12100367
14.

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.

Davidson BL, Büller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Lensing AW; Matisse Investigators.

J Thromb Haemost. 2007 Jun;5(6):1191-4.

15.

Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.

Shorr AF, Sarnes MW, Peeples PJ, Stanford RH, Happe LE, Farrelly E.

Am J Health Syst Pharm. 2007 Nov 15;64(22):2349-55.

PMID:
17989444
16.

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.

Renda G, Di Pillo R, D'Alleva A, Sciartilli A, Zimarino M, De Candia E, Landolfi R, Di Giammarco G, Calafiore A, De Caterina R.

Haematologica. 2007 Mar;92(3):366-73.

17.

Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.

Simone EP, Madan AK, Tichansky DS, Kuhl DA, Lee MD.

Surg Endosc. 2008 Nov;22(11):2392-5. doi: 10.1007/s00464-008-9997-6. Epub 2008 Jul 2.

PMID:
18594915
18.

Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy.

Kaaja R, Lehtovirta P, Venesmaa P, Kajanoja P, Halonen P, Gummerus M, Partanen S.

Eur J Obstet Gynecol Reprod Biol. 1992 Nov 19;47(2):141-5.

PMID:
1333998
19.

[Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].

Omran H, Hammerstingl C, Paar WD; Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.

Med Klin (Munich). 2007 Oct 15;102(10):809-15. German.

PMID:
17928964
20.

Supplemental Content

Support Center